Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ultrasound study tests metoclopramide for stomach safety in diabetic surgery patients

NCT ID NCT07519447

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving metoclopramide, a drug that speeds up stomach emptying, helps diabetic patients have less stomach fluid before surgery. 60 adults having elective surgery were checked with ultrasound to measure stomach contents. The goal was to see if the drug lowers the risk of food or liquid entering the lungs during anesthesia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

60 people

The number who actually took part.

Started

Mar 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study was carried out on 60 patients undergoing elective surgery admitted to Kafr- Elsheikh University Hospitals over a period of 6 months starting from approval of the Medical Sciences Ethics Committee of Kafr- Elsheikh Faculty of Medicine.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age from 18 to 65 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-II. * Underwent elective surgery. Exclusion Criteria: * Patients taking drugs that affect gastric motility. * Patients with renal failure. * Hypothyroidism. * Obesity \[body mass index (BMI) \> 30kg/m2\]. * Connective tissue disorders. * History of gastrointestinal surgery. * Those with steroid-induced hyperglycemia. * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aspiration risk are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kafrelsheikh University

    Kafr ash Shaykh, Kafrelsheikh, 33516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.